Symptom triggered screening for ovarian cancer: A pilot study of feasibility and acceptability

Gynecologic Oncology

Volumn 124, Issue 2, 2012, Pages 230-235

  Goff, Barbara A ^a   Lowe, Kimberly A ^c,d   Kane, Jeannette C ^a   Robertson, Marissa D ^a   Gaul, Marcia A ^b   Andersen, M Robyn ^b,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d Exponent Health Sciences   (United States)

Author keywords

Ovarian cancer; Screening; Symptoms

Indexed keywords

CA 125 ANTIGEN;

ADULT; ARTICLE; CANCER PATIENT; CANCER REGISTRY; CANCER SCREENING; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CURETTAGE; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; ENDOMETRIOSIS; ENDOMETRIUM BIOPSY; FALSE NEGATIVE RESULT; FEASIBILITY STUDY; FEMALE; HEALTH CARE PERSONNEL; HEALTH SURVEY; HISTOPATHOLOGY; HUMAN; HYSTEROSCOPY; LAPAROSCOPY; LAPAROTOMY; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVARY CANCER; PILOT STUDY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RATING SCALE; SENSITIVITY AND SPECIFICITY; SYMPTOM; SYMPTOM INDEX; TRANSVAGINAL ECHOGRAPHY;

EARLY DETECTION OF CANCER; FEASIBILITY STUDIES; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; PILOT PROJECTS; PROSPECTIVE STUDIES; QUESTIONNAIRES; SEER PROGRAM; WASHINGTON;

EID: 84855989333     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.10.032     Document Type: Article

References (26)

1. US Preventive Services Task Force Agency for Healthcare Research and Quality Screening for Ovarian Cancer, Topic Page 2004 US Department of Health and Human Services Rockville, MD
2. E. Partridge Results from 4 rounds of ovarian cancer screening in a randomized trial Obstet Gynecol 113 2009 775 782
3. S.S. Buys, E. Partridge, and A. Black Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening randomized controlled trial JAMA 305 22 2011 2295 2303
4. U. Menon, A. Gentry-Maharaj, and R. Hallett Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) Lancet Oncol 10 4 2009 327 340
5. U. Menon, and I.J. Jacobs Ovarian cancer screening in the general population Curr Opin Obstet Gynecol 13 2001 61 64 (Pubitemid 32667437)
6. I.J. Jacobs, and U. Menon Progress and challenges in screening for ovarian cancer Mol Cell Proteomics 3 2004 355 366 (Pubitemid 38702089)
7. D.K. Armstrong, B. Bundy, and L. Wenzel Phase III randomized trial of intravenous cisplatin and paclitaxel versus an intensive regimen of intravenous paclitaxel, and intraperitoneal paclitaxel in stage III ovarian cancer: a Gynecologic Oncology Group study N Engl J Med 354 2006 334 343
8. R.E. Bristow, R.S. Tomacruz, D.K. Armstrong, E.L. Trimble, and F.J. Montz Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis J Clin Oncol 20 5 2002 1248 1259 (Pubitemid 34177431)
9. B.A. Goff, L.S. Mandel, and S.W. Drescher Development of an ovarian cancer symptom index: possibilities for earlier detection Cancer 109 2007 221 227 (Pubitemid 46106236)
10. K.A. Lowe, M.R. Andersen, N. Urban, P. Paley, C.W. Drescher, and B.A. Goff The temporal stability of the Symptom Index among women at high-risk for ovarian cancer Gynecol Oncol 114 2 2009 225 230
11. B.A. Goff, L. Mandel, H.G. Muntz, and C.H. Melancon Ovarian carcinoma diagnosis Cancer 89 2000 2068 2075
12. B.A. Goff, L.S. Mandel, C.H. Melancon, and H.G. Muntz Frequency of symptoms of ovarian cancer in women presenting to primary care clinics JAMA 291 2004 2705 2712 (Pubitemid 38725419)
13. S.M. Devlin, P.H. Diehr, M.R. Andersen, B.A. Goff, P.T. Tyree, and M.E. Lafferty Identification of ovarian cancer symptoms in health insurance claims data J Womens Health (Larchmt) 19 2010 381 389
14. W. Hamilton, T.J. Peters, C. Bankhead, and D. Sharp Risk of ovarian cancer in women with symptoms in primary care: population based case-control study BMJ 339 2009 b2998
15. M.F. Vine, B. Calingaert, A. Berchuck, and J.M. Schildkraut Characterization of prediagnostic symptoms among primary epithelial ovarian cancer cases and controls Gynecol Oncol 90 2003 75 82 (Pubitemid 37338079)
16. L.H. Smith, C.R. Morris, S. Yasmeen, A. Parikh-Patrl, R.D. Cress, and P.S. Romano Ovarian cancer: can me make the clinical diagnosis earlier? Cancer 104 2005 1398 1407 (Pubitemid 41356155)
17. S.H. Olson, L. Mignone, C. Nakraseive, T.A. Caputo, R.R. Barakat, and S. Harlap Symptoms of ovarian cancer Obstet Gynecol 98 2001 212 217 (Pubitemid 32744751)
18. P.B. Yawn, B.A. Barrette, and P.C. Wollan Ovarian cancer: the neglected diagnosis Mayo Clin Proc 79 2004 1277 1282 (Pubitemid 39299073)
19. N. Behtash, E. Ghayouri Azar, and F. Fakhrejahani Symptoms of ovarian cancer in young patients 2 years before diagnosis, a case-control study Eur J Cancer Care (Engl) 17 2008 483 487
20. G.D. Freidman, J.S. Skilling, N.V. Udaltsove, and L.H. Smith Early symptoms of ovarian cancer: a case-control study without recall bias Fam Pract 22 2005 548 553 (Pubitemid 41418776)
21. M.K. Kim, K. Kim, and S.M. Kim A hospital-based case control study of identifying ovarian cancer using a symptom index J Gynecol Oncol 20 2009 238 242
22. M.R. Andersen, B.A. Goff, and K.A. Lowe Combining a symptoms index with CA125 to improve detection of ovarian cancer Cancer 113 3 2008 484 489
23. M.R. Andersen, B.A. Goff, and K.A. Lowe Use of a symptom index, CA125, and HE4 to predict ovarian cancer Gynecol Oncol 116 3 2010 378 383
24. E.J. Pavlik, B.A. Saunders, and S. Doran The search for meaning - symptoms and transvaginal sonography screening for ovarian cancer Cancer 115 2009 3689 3698
25. R. Fox Commentary: diagnosing ovarian cancer, more problems than answers BMJ 339 2009
26. I. Cass The search for meaning - symptoms and transvaginal sonography screening for ovarian cancer Cancer 115 2009 3606 3609